The Drug Enforcement Administration (DEA) has announced that the appeal process for marijuana rescheduling remains pending, despite prior instructions from President Trump for expedited action. This delay marks more than three months without a set briefing schedule.
In related findings, a former senior advisor to the DEA has coauthored an analysis arguing that existing federal marijuana laws lack coherence and are not evidence-based, causing significant harm. The report calls for a restructured approach, proposing a managed market access schedule for substances like cannabis and psilocybin to replace current criminalization methods.
State-Level Developments
Rep. Thomas Massie (R-KY) voiced support for allowing states to legalize cannabis independently of federal law, highlighting his preference for “medical margaritas” over recreational marijuana. Meanwhile, Pennsylvania Governor Josh Shapiro has intensified his advocacy for marijuana legalization, citing potential revenue increases for investments in education, public safety, and the economy.
In Missouri, Governor Mike Kehoe (R) has endorsed a bill aimed at regulating intoxicating hemp-derived THC products, emphasizing the necessity of passing such measures.
Conversely, the Idaho House of Representatives has passed a resolution discouraging voters from supporting a medical cannabis initiative for the upcoming November ballot, arguing that such legalization may lead to increased crime and health issues.
In Ohio, a judge has issued a temporary restraining order halting the enforcement of new hemp product regulations, stating that these restrictions unfairly protect the in-state marijuana industry from out-of-state competition concerning federally legal hemp products.
Federal Initiatives and Local Insights
The White House Office of National Drug Control Policy recently held an awards ceremony recognizing law enforcement efforts against drug trafficking. On the legislative front, a House bill to establish psychedelic therapy centers of excellence now counts 25 cosponsors.
In Oklahoma, Republican candidates for governor addressed their concerns about medical cannabis during a recent debate. Florida’s agriculture commissioner reiterated their successful legal stance against challenges from the hemp industry regarding protections for children from high-potency THC hemp products.
In Massachusetts, the Senate Ways and Means Committee has proposed $1 million for public education on marijuana risks. Additionally, Illinois’s Medical Cannabis Advisory Board recommended adding sickle cell disease to the list of qualifying conditions for medical marijuana.
Regulators in Vermont have issued guidance on cannabis regulations ahead of the 4/20 celebration, while California has updated its policies on transitioning provisional cannabis licenses to annual licenses.
On the local level, the Minneapolis City Council is contemplating a proposal to decriminalize drug paraphernalia.
Scientific Research and Market Trends
Research in Germany has shown no increase in cannabis consumption following legalization. Another study indicates that including cannabis seed in poultry feed may positively alter lipid metabolism and fat profiles without adversely affecting growth.
Business developments include Vireo Growth Inc.’s partnership with Ace Venture of NY, LLC, aiming to establish New York’s first social equity operator under the state’s minority-owned medical cannabis license.
Lastly, notable figures in entertainment are also stepping into the cannabis space as Jimmy Kimmel prepares to executive produce a new Hulu docuseries focused on cannabis culture.